Latest Market Updates News

Coventry Group reports a solid half-year sales and earnings improvement while initiating a strategic review following unsolicited takeover interest.

Morella Corporation has initiated Federal Court proceedings against former receivers over disputed proceeds from a 2020 asset sale, aiming to recover value for shareholders without disrupting current operations.

Triton Minerals has executed a pivotal Shareholders Cooperation Deed with NQM Gold 2 Pty Ltd, marking significant progress under their Share Sale and Purchase Agreement. This step sets the stage for governance arrangements ahead of project completion.

Triton Minerals Limited has formally retracted certain visual estimates of mineralisation from its recent market update, acknowledging non-compliance with ASX reporting standards and urging investors to disregard these figures.

US1 Critical Minerals has obtained a Federal Court undertaking preventing the transfer or encumbrance of disputed Rare Earth tenements in California, with a trial scheduled for April 2026.

Star Minerals Limited has requested an extension to its voluntary suspension on the ASX as it awaits a Supreme Court ruling on the appointment of its auditor, with a market update expected soon.

Perpetual Limited has extended its exclusivity agreement with Bain Capital into early 2026 as discussions continue over the potential sale of its Wealth Management business. While progress is steady, no binding deal is yet assured.

DEXUS has announced an estimated ordinary distribution of AUD 0.193 per unit for the six months ending December 2025, marking a steady income stream for investors ahead of the new year.

GrainCorp announces the sale of its Canadian joint venture GrainsConnect to Parrish & Heimbecker for C$150 million, alongside a trading update revealing lower expected grain receivals in Australia’s 2025-26 winter harvest.

Fiducian Group’s subsidiary Fiducian Investment Management Services Limited has filed a defence after ASIC initiated civil proceedings alleging misleading disclosure and compliance failures related to a managed fund.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Mayfield Group Holdings has successfully closed an oversubscribed share purchase plan, raising over $5 million against a $3 million target, prompting a pro rata scale-back for larger applications.